News

The Food and Drug Administration is reconsidering its decision not to approve a drug that an Omaha mom says is saving her son ...
Hallucinations are a known problem with generative AI models—and Elsa is no different, according to Jeremy Walsh, the head of ...
Learn how ATTR-CM is treated with medications that slow down the condition's progression and other therapies that reduce symptoms and improve the quality of life.
Missouri's Republican attorney general filed a lawsuit on Wednesday accusing reproductive healthcare provider Planned ...
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...
Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med. | Ahead of the 10-year ...
The Trump administration reportedly plans to eliminate an Environmental Protection Agency rule that’s crucial to the federal ...
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...
The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in ...
The Trump Administration rolled out a plan to reign in regulations to speed up the development of AI tools and the infrastructure to power them. 'The Action Plan's objective is to articulate policy ...
The FDA has accepted for Priority Review the BLA for tividenofusp alfa for the treatment of Hunter syndrome, also known as MPS II.